Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $1187.95 ($118K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($118k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1166.52 | 4 | $5K | 4.0% |
| 2 | $1167.27 | 1 | $1K | 1.0% |
| 3 | $1168.99 | 4 | $5K | 4.0% |
| 4 | $1170.40 | 4 | $5K | 4.0% |
| 5 | $1172.75 | 16 | $19K | 15.9% |
| 6 | $1174.32 | 8 |
| $9K |
| 8.0% |
| 7 | $1175.66 | 8 | $9K | 8.0% |
| 8 | $1176.82 | 4 | $5K | 4.0% |
| 9 | $1177.73 | 4 | $5K | 4.0% |
| 10 | $1178.69 | 4 | $5K | 4.0% |
| 11 | $1179.62 | 8 | $9K | 8.0% |
| 12 | $1183.47 | 8 | $9K | 8.0% |
| 13 | $1184.26 | 1 | $1K | 1.0% |
| 14 | $1185.77 | 4 | $5K | 4.0% |
| 15 | $1186.19 | 5 | $6K | 5.0% |
| 16 | $1187.95 | 3 | $4K | 3.0% |
| 17 | $1188.55 | 4 | $5K | 4.0% |
| 18 | $1189.13 | 5 | $6K | 5.0% |
| 19 | $1190.00 | 1 | $1K | 1.0% |
| 20 | $1191.02 | 4 | $5K | 4.0% |
| Total | $1178.68 avg | 100 | $118K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |